☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
PharmaTher
PharmaTher Entered into a Development Agreement with CCBIO to Develop and Commercialize Wearable Ketamine Delivery Device
May 25, 2022
PharmaTher Reports Results of Ketamine in a Clinical Study for the Treatment of Parkinson’s Disease
March 24, 2022
PharmaShots Weekly Snapshots (October 11 - 15, 2021)
October 15, 2021
PharmaShots Weekly Snapshots (October 04 - 08, 2021)
October 8, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.
